The ingredient now has a flavor profile that is similar to milder, non-organic forms of spirulina – which should broaden its consumer appeal. Valensa and Parry Nutraceuticals worked with research and consulting firm the AIBMR Life Sciences, Inc. (Puyallup, WA) to facilitate the recognition by the FDA.
